| Literature DB >> 24974092 |
Friederike Krämer1, Roland Schaper, Bettina Schunack, Andrzej Połozowski, Jolanta Piekarska, Aleksandra Szwedko, Robert Jodies, Dagmara Kowalska, Dörte Schüpbach, Nikola Pantchev.
Abstract
Canine vector-borne diseases (CVBDs) have increasingly become a focus of attention in the past few years. Nevertheless, in many parts of Europe information on their occurrence is still scarce. In a large study in Poland 3,094 serum samples taken from dogs throughout all 16 Polish provinces were tested using a commercial kit for the detection of circulating antibodies against Anaplasma phagocytophilum, Borrelia burgdorferi sensu lato and Ehrlichia canis and of Dirofilaria immitis antigen. A total of 12.31% (381/3,094; 95% confidence interval [CI]: 11.18-13.52%) and 3.75% (116/3,094; 95% CI: 3.11-4.48%) of the dogs were positive for A. phagocytophilum and B. burgdorferi s.l. antibodies, respectively. Furthermore, 0.26% (8/3,094; 95% CI: 0.11-0.51%) were positive for E. canis antibodies and 0.16% (5/3,094; 95% CI: 0.05-0.38%) for D. immitis antigen. The highest percentages of A. phagocytophilum-positive dogs were noted in Lesser Poland, Silesia and Łódź Provinces. For B. burgdorferi s.l., the highest prevalence was recorded in Łódź Province. Co-infections with A. phagocytophilum and B. burgdorferi s.l. were recorded in 1.71% of all examined dogs (53/3,094; 95% CI: 1.29-2.23%). One dog even had a triple infection, testing positive for E. canis too. Both A. phagocytophilum and B. burgdorferi s.l. have previously been reported in Poland and were confirmed in the present study by positive samples from all 16 provinces. Concerning E. canis and D. immitis travel history or importation cannot be excluded as factors which may have determined the occurrence of these pathogens in the relevant animals. Practitioners in Poland should be aware of the above mentioned CVBDs and of prophylactic measures to protect dogs and their owners.Entities:
Mesh:
Substances:
Year: 2014 PMID: 24974092 PMCID: PMC4143602 DOI: 10.1007/s00436-014-3985-7
Source DB: PubMed Journal: Parasitol Res ISSN: 0932-0113 Impact factor: 2.289
Fig. 1Canine SNAP® 4Dx® test device. Schematic illustration (left) and photograph of a test device demonstrated with a canine serum sample positive for Borrelia and Anaplasma antibodies (right)
Results of dog serum samples from Poland (n = 3,094) tested for the presence of specific antibodies against Anaplasma phagocytophilum (Ap), Borrelia burgdorferi s.l. (Bb) and Ehrlichia canis (Ec) and of circulating antigen of Dirofilaria immitis (Di)
| Causative organism | Antibody (Ap, Bb, Ec) or antigen (Di) positive dogs/all tested dogs | Percentage | 95 % Confidence interval |
|---|---|---|---|
|
| 381/3,094 | 12.31 % | 11.18–13.52 % |
|
| 116/3,094 | 3.75 % | 3.11–4.48 % |
|
| 8/3,094 | 0.26 % | 0.11–0.51 % |
|
| 5/3,094 | 0.16 % | 0.05–0.38 % |
Fig. 2Occurrence of Anaplasma phagocytophilum-positive dogs detected by SNAP® 4Dx® in a population of 3,094 from Poland. Dark grey areas represent the origin of the tested dog sera. The origins of dogs positive for circulating A. phagocytophilum antibodies (n = 381) are shown in red
Fig. 3Occurrence of Borrelia burgdorferi s.l. -positive dogs detected by SNAP® 4Dx® in a population of 3,094 from Poland. Dark grey areas represent the origin of the tested dog sera. The origins of dogs positive for circulating B. burgdorferi s.l. antibodies (n = 116) are shown in blue
Fig. 4Occurrence of Ehrlichia canis- and Dirofilaria immitis-positive dogs detected by SNAP® 4Dx® in a population of 3,094 from Poland. Dark grey areas represent the origin of the tested dog sera. The origins of dogs positive for circulating E. canis antibodies (n = 8) and D. immitis antigen (n = 5) are shown in green and orange, respectively
Distribution of Anaplasma phagocytophilum (Ap), Borrelia burgdorferi s.l. (Bb), Ehrlichia canis (Ec) and Dirofilaria immitis (Di) positive samples per province (percentage and total numbers)
| Province (number of veterinary clinics) | Percentage Ap positive ( | Percentage Bb positive ( | Percentage Ec positive ( | Percentage Di positive ( | Percentage Ap + Bb positive ( | Percentage Ap + Bb + Ec positive ( |
|---|---|---|---|---|---|---|
| Greater Poland (5) | 12.72 % (43/338) | 2.66 % (9/338) | 0.30 % (1/338) | 0.30 % (1/338) | 0.89 % (3/338) | |
| Kuyavia-Pomerania (1) | 10.26 % (8/78) | 6.41 % (5/78) | 1.28%c (1/78) | |||
| Lesser Poland (4) | 25.24 % (53/210) | 3.81 % (8/210) | 2.86 % (6/210) | |||
| Łódź (4) | 20.28 % (43/212) | 11.32 % (24/212) | 8.49 % (18/212) | |||
| Lower Silesia (3) | 13.39 % (15/112) | 5.36 % (6/112) | 1.79 % (2/112) | |||
| Lublin (5) | 7.50 % (24/320) | 2.19 % (7/320) | 0.94 % (3/320) | 0.94 % (3/320) | ||
| Lubusz (3) | 16.49 % (32/194) | 4.64 % (9/194) | 0.52 % (1/194) | 1.55 % (3/194) | 0.52 % (1/194) | |
| Masovia (2) | 3.21 % (5/156) | 0.64 % (1/156) | 0.64 % (1/156) | 0.64 % (1/156)/ 0.0 % (0/156)a | ||
| Opole (1) | 15.00 % (18/120) | 6.67 % (8/120) | 0.83 % (1/120) | 1.67 % (2/120) | ||
| Podlaskie (2) | 9.68 % (12/124) | 1.61 % (2/124) | 0.81 % (1/124) | |||
| Pomerania (6) | 8.23 % (20/243) | 1.65 % (4/243) | 0.41 % (1/243) | 0.41 % (1/243) | 0.82 % (2/243) | |
| Silesia (3) | 20.90 % (42/201) | 5.97 % (12/201) | 3.48 % (7/201) | |||
| Subcarpathia (2) | 4.27 % (5/117) | 2.56 % (3/117) | ||||
| Świętokrzyskie (2) | 4.80 % (6/125) | 1.60 % (2/125) | 0.80 % (1/125) | |||
| Warmia-Masuria (5) | 8.73 % (20/229) | 2.62 % (6/229) | 0.44 % (1/229) | 0.87 % (2/229) | ||
| West Pomerania (6) | 11.11 % (35/315) | 3.17 % (10/315) | 0.95 % (3/315) | |||
| Total (54) | 12.31 % (381/3,094) | 3.75 % (116/3,094) | 0.26 % (8/3,094) | 0.16 % (5/3,094)/0.13 % (4/3,094)a | 1.71 % (53/3,094) | 0.03 % (1/3,094) |
x samples positive for a specific pathogen, y total number of samples tested per province
aCorrected data after discounting one potential A. vasorum cross-reacting dog in Masovia Province
Proportion of single, double and triple infections in positive samples (n = 456)
| Ap (alone) | Bb (alone) | Ec (alone) | Di | Ap + Bb | Ap + Bb + Ec | |
|---|---|---|---|---|---|---|
| Positive samples | 328 | 63 | 7 | 5 | 52 | 1 |
| Percentage (95 % CI) | 71.93 % (67.56–76.01 %) | 13.82 % (10.78–17.33 %) | 1.54 % (0.62–3.14 %) | 1.10 % (0.36–2.54 %) | 11.40 % (8.63–14.68 %) | 0.22 % (0.01–1.22 %) |
Ap Anaplasma phagocytophilum, Bb Borrelia burgdorferi s.l., Di Dirofilaria immitis, Ec Ehrlichia canis, CI confidence interval